Press release
Gout Therapeutics Market on Track for Strong Growth, Estimated to Grow at 11.7% CAGR Through 2029
Gout Therapeutics Market
What Is the Expected CAGR for the Gout Therapeutics Market Through 2025?
The market size for gout therapeutics has expanded significantly in recent times. It is projected to rise from $2.88 billion in 2024 to a substantial $3.23 billion by 2025, marking a compound annual growth rate (CAGR) of 12.2%. The historical period of growth is due to factors such as the rising prevalence of gout, changes in lifestyle and diet patterns, the increase in high blood pressure and diabetes incidence, the advancement of xanthine oxidase inhibitors, and initiatives to educate patients.
What's the Projected Size of the Global Gout Therapeutics Market by 2029?
There is a prediction for rapid expansion in the gout therapeutics market size in the coming years. The market is expected to grow to $5.03 billion by 2029, with a compound annual growth rate (CAGR) of 11.7%. The predicted growth during this period can be linked to the increase in healthcare spending, advancements in medication delivery systems, the emergence of new treatment therapies, government-led initiatives for managing chronic diseases, and groups advocating for patient support. Key market trends to watch out for during this forecast period include the development and approval of innovative drugs, personalized treatment plans, utilization of telehealth services in managing gout, and research into therapies that lower urate levels.
View the full report here:
https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report
Top Growth Drivers in the Gout Therapeutics Industry: What's Accelerating the Market?
The escalating prevalence of gout is anticipated to fuel the expansion of the gout therapeutics market in the future. Gout is an inflammatory arthritis disorder that triggers joint pain and swelling. Therapies for gout aim to treat and alleviate joint discomfort, swelling, and tenderness. Consequently, the escalating rate of gout is predicted to amplify sales in the gout therapeutics market. For example, the Australian Institute of Health and Welfare, a United States government establishment, stated in June 2024 that gout was marked as a fundamental and contributing factor in 573 fatalities in Australia in 2022, translating to 2.2 deaths for every 100,000 individuals. Thus, the escalating prevalence of gout is propelling the expansion of the gout therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12118&type=smp
What Trends Will Shape the Gout Therapeutics Market Through 2029 and Beyond?
The increasing popularity of product innovation is a noticeable trend in the gout therapeutics market. To maintain their market dominance, key players in the gout therapeutics industry are creating novel treatment approaches. For example, Synlogic Inc., an American pharmaceutical firm, launched SYNB2081, a breakthrough drug for gout therapy in August 2022. The drug, SYNB2081, is a synthetic biotic meant to reduce uric acid levels. This is the second clinical medicine from a research partnership between Synlogic and Ginkgo, an American biotech firm.
What Are the Main Segments in the Gout Therapeutics Market?
The gout therapeutics market covered in this report is segmented -
1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics
2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication
3) By Disease Condition: Acute, Chronic
4) By End-Users: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, Selective COX-2 Inhibitors
2) By Corticosteroid: Oral Corticosteroids, Injectable Corticosteroids
3) By Diuretics: Thiazide Diuretics, Loop Diuretics
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12118&type=smp
Which Top Companies are Driving Growth in the Gout Therapeutics Market?
Major companies operating in the gout therapeutics market include Sanofi-Aventis, AstraZeneca plc, LG Chem Ltd., GlaxoSmithKline Plc, Takeda Pharmaceuticals Co. Ltd., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Sandoz, Eisai Co. Ltd., Horizon Pharma Plc, Jiangsu HengRui Medicine Co. Ltd., Hikma Pharmaceuticals plc, Swedish Orphan Biovitrum AB, JW Pharmaceutical Corp, Lannett Company Inc, BioCryst Pharmaceuticals Inc., Selecta Biosciences Inc., Rigel Pharmaceuticals Inc., CymaBay Therapeutics Inc., GeneScience Pharmaceuticals Co. Ltd., Shanton Pharma
Which Regions Will Dominate the Gout Therapeutics Market Through 2029?
North America was the largest region in the gout therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12118
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gout Therapeutics Market on Track for Strong Growth, Estimated to Grow at 11.7% CAGR Through 2029 here
News-ID: 4098638 • Views: …
More Releases from The Business Research Company
Leading Companies Solidify Their Presence in the Silicone Structural Glazing Mar …
The silicone structural glazing market is positioned for significant expansion in the coming years, driven by advances in building technology and increased environmental awareness. This sector is evolving rapidly as demand grows for more energy-efficient and aesthetically appealing architectural solutions. Let's explore the market's current size, key players, emerging trends, and the main segments that are shaping its future.
Silicone Structural Glazing Market Value Forecast Through 2030
The market for silicone…
Future Prospects: Key Trends Shaping the Self-Healing Concrete Market up to 2030
The self-healing concrete market is capturing significant attention as innovations and sustainability demands rise in construction. This sector is set to experience remarkable growth due to advancements in materials and technology, shaping the future of durable and intelligent infrastructure solutions. Let's explore the market's size, key players, emerging trends, and segment outlook to understand its trajectory.
Projected Market Size and Growth Prospects for the Self-Healing Concrete Market
The self-healing concrete market…
Analysis of Key Market Segments Driving the ROS-Based Robot Industry
The ROS-based robot market is positioned for substantial growth as robotics technology continues to advance rapidly. With increasing innovation in software, hardware, and AI integration, this sector is set to transform multiple industries by 2030. Below, we explore the market's future size, leading companies, key trends, and segmentation details to understand its evolving landscape.
Projected Market Size and Expansion of the ROS-Based Robot Market
The ROS-based robot market is anticipated to…
Global Trends Overview: The Rapid Evolution of the Robotic Panelized Home Builde …
The robotic panelized home builder market is positioned for impressive growth in the coming years as automation and robotics increasingly transform construction processes. Driven by technological advancements and expanding prefab housing projects, this market is set to reshape how homes are built with greater speed and efficiency. Let's explore the market's size, leading companies, emerging trends, and key segments that are shaping its future.
Strong Growth Forecast for the Robotic Panelized…
More Releases for Gout
Chronic Gout Market Trends, Therapeutics, and Growth Opportunities
Chronic gout is a progressive form of arthritis characterized by elevated uric acid levels, leading to severe joint pain, inflammation, and long-term joint damage. This condition affects millions worldwide, often resulting in impaired mobility and reduced quality of life. With rising prevalence due to lifestyle changes, aging populations, and dietary habits, the Chronic Gout market is witnessing a surge in demand for advanced therapeutics, early diagnostics, and patient management solutions.
Download…
Chronic Gout Market Massive Growth opportunity Ahead
Introduction
Chronic gout is a form of arthritis characterized by recurrent attacks of severe pain, swelling, and inflammation in the joints, often due to the accumulation of uric acid crystals. This condition typically affects the big toe but can also impact other joints, including the knees, elbows, and wrists. Uric acid, a by-product of purine metabolism, accumulates in the body due to overproduction or underexcretion by the kidneys, leading to hyperuricemia…
Gout Market Innovations in Pain Management and Treatment
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Gout Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many…
Gout Therapeutics Market Analysis By Drug Class (Nonsteroidal Anti-inflammatory …
Report Summary
The global gout therapeutics market was valued at USD 2.78 Billion in 2021 and is expected to grow at a CAGR of 13.7% during the forecast period 2023-2032.
Gout Therapeutics Market Introduction
The deposition of monosodium crystals (MSU) into the distal joints and peripheral tissues results in gout, an inflammatory arthritic disease. Gout is a typical type of painful inflammatory arthritis. One joint is typically affected at a time (often…
Global Gout Drugs Market Analysis (2020-2025)
Global Info Research offers a latest published report on Gout Drugs Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Gout Drugs Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/reports/371311/gout-drugs
Market…
Gout Therapeutics Market Emerging Trends And Forecast By 2025
Global Gout Therapeutics Market: Snapshot
The objective of treatment during a severe gout attack involves suppressing inflammation and controlling pain. The treatment of inflammation and pain can be attained with non-steroidal anti-inflammatory drugs, colchicine, or corticosteroids. The line of treatment chosen that would be suitable depends on the co-morbid medical conditions of the patient, side effect profile, and other medications.
Patients with multiple episodes of severe gout attacks every year or with…
